Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 19 Show results per page	View Search Criteria \| Help With Results

Last Modified: 1/12/2004 First Published: 9/1/2002


1.		Phase I/II Study of UCN-01 and Fludarabine in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				NCI				PMH-PHL-006 NCI-5538, NCT00045513, 5538

Last Modified: 12/22/2003 First Published: 2/1/2002


2.		Phase II Study of UCN-01 in Patients With Unresectable Advanced or Metastatic Renal Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				UCSF-NCI-5522 NCI-5522, NCT00030888, 5522

Last Modified: 4/23/2007 First Published: 9/1/2002


3.		Phase II Study of UCN-01 and Fluorouracil in Patients With Gemcitabine-Refractory Metastatic Pancreatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				MSKCC-02049 NCI-5509, 5509, NCT00045747

Last Modified: 5/16/2007 First Published: 10/25/2003


4.		Phase II Study of UCN-01 in Patients With Metastatic Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				CCC-PHII-33 UCD-200311478-01, CHNMC-PHII-33, NCI-5536, NCT00072189, 5536

Last Modified: 5/12/2005 First Published: 10/25/2003


5.		Phase II Study of UCN-01 and Topotecan in Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				PMH-PHL-019 NCI-6402, NCT00072267, 6402

Last Modified: 10/23/2007 First Published: 11/22/2004


6.		Phase II Study of UCN-01 and Topotecan in Patients With Small Cell Lung Cancer That Relapsed or Progressed After Prior First-Line Platinum-Based Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				PMH-PHL-032 NCI-6992, 6992, NCT00098956

Last Modified: 12/20/2007


7.		Phase I Study of Continuous-Infusion UCN-01 (a Staurosporine Analogue) in Patients With Refractory Solid Tumors or Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				Over 18				NCI				NCI-95-C-0171N NCI-T95-0052N, T95-0052

Last Modified: 9/1/2001 First Published: 6/1/1998


8.		Phase I Study of UCN-01 in Patients with Advanced Solid Tumors or Chronic Lymphoproliferative Disorders (Summary Last Modified 09/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				JHOC-98012305 NCI-T97-0083, NCT00003289

Last Modified: 10/10/2008 First Published: 9/1/1999


9.		Phase I Study of UCN-01 and Fludarabine in Patients With Recurrent or Refractory Low-Grade or Indolent Lymphoid Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				NCI-99-C-0127 NCI-T99-0022, T99-0022, NCT00019838

Last Modified: 12/1/2002 First Published: 10/1/1999


10.		Phase I Study of Fluorouracil With UCN-01 in Patients With Advanced or Refractory Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				MSKCC-9924 NCI-T99-0037, NCT00004059, T99-0037

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute